Preclinical Research

Jan 27, 2026

0 likes | 1 Vues

Accelerate device validation through preclinical research with GLP-compliant studies, advanced surgical models, expert protocols, and fast regulatory-ready.

IBEX5

Télécharger la présentation

Preclinical Research

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

IBEX Preclinical Research, Inc. At IBEX Preclinical Research we pride ourselves on being a lean mean machine. We will get your study initiated quickly with lead times as short as 3 weeks, prompt access to pertinent surgical images or worksheets during the in-vivo portion, and superior turnaround on the report. Preclinical Research Accelerate device validation through preclinical research with GLP-compliant studies, advanced surgical models, expert protocols, and fast regulatory-ready. Preclinical Research Facility Support faster validation through a preclinical research facility combining expert-led protocols, advanced surgical models & compliant preclinical testing. Medical Device Testing Strengthen regulatory confidence via medical device testing delivering precise protocols, expert execution, and high quality preclinical data you can trust. Contact Us info@ibexresearch.com (435) 752-4448 https://ibexresearch.com/

Preclinical Animal Studies for Cardiovascular Devices

Preclinical Animal Studies for Cardiovascular Devices. Victoria Hampshire, VMD Division of Cardiovascular Devices US Food and Drug Association White, Oak, MD June 24, 2010 vahampshire@fda.hhs.gov 301-796-6375. Objectives of Today’s Interaction.

682 views • 18 slides

Xybion announces a major biotechnology company licenses Pris

(1888PressRelease) Xybion Corporation announced that its Pristima Preclinical Software suite has been selected as the primary preclinical platform for early-stage drug discovery pathology data management by a Top-5 global biotech firm.

180 views • 2 slides

Preclinical-Bench Testing II Using Human Observers to Objectively Measure and Evaluate Imaging Performance of Digital

Preclinical-Bench Testing II Using Human Observers to Objectively Measure and Evaluate Imaging Performance of Digital WSI Systems. Max Robinowitz, MD FDA Center for Devices and Radiological Health October 22, 2009. Object Related Diagnosis Please look at this picture 

368 views • 20 slides

Preclinical Studies Showing Protection of Normal Tissues and Lack of Protection for Tumors

Preclinical Studies Showing Protection of Normal Tissues and Lack of Protection for Tumors. Stephen Brown Henry Ford Hospital, Detroit MI. Intervention Timing. Radiation Exposure. Time. 3) Weeks to months after radiation exposure - potential to regenerate normal tissue using stem cells

702 views • 22 slides

Knowledge Update Clinical documentation: from preclinical studies to drug registration

Knowledge Update Clinical documentation: from preclinical studies to drug registration. Split, 12 September 2008. Clinical programme. Registration. Drug discovery. Preclinical development. Company. Regulatory Agency FDA (US) EMEA (EU). Overview of drug development.

446 views • 17 slides

Dual mTOR/HDAC inhibition: preclinical development of a novel breast cancer therapy

Dual mTOR/HDAC inhibition: preclinical development of a novel breast cancer therapy Mariya Yevtushenko, Kathleen A. Wilson- Edell , and Christopher C. Benz Buck Institute for Research on Aging, Novato, CA. Background. 2 . MLN0128 and TSA synergistically decrease breast cancer cell viability.

305 views • 1 slides

Preclinical and Biodistribution Assessments Supporting Development of Gene Therapy Products

Preclinical and Biodistribution Assessments Supporting Development of Gene Therapy Products. Janet M. Benson, PhD, DABT Lovelace Respiratory Research Institute, Albuquerque, NM. About LRRI. Founded in 1947 in the State of New Mexico Three subsidiaries

504 views • 30 slides

Preclinical Models for Developing Therapy for Pediatric Solid Tumors uses and limitations

Preclinical Models for Developing Therapy for Pediatric Solid Tumors uses and limitations. Peter J. Houghton, Ph.D. Solid Malignancies Program St. Jude Children’s Research Hospital. Problems in using Preclinical Data. Early drug discovery is conducted under defined/standardized environment.

407 views • 23 slides

Increasing the Reliability of Preclinical Research

Increasing the Reliability of Preclinical Research. 4 :45 PM - 5:00 PM Does Our System Impair Honest Reporting of Data ?: Lee M. Ellis, MD 5 :00 PM - 5:15 PM The Experience of Industry in Trying to Validate Data from Academic Labs: Colin G. Begley, PhD, MBBS 5 :15 PM - 5:30 PM

400 views • 27 slides

HCS 465 (Health Care Research Utilization) Entire Class Assignme

HCS 465 (Health Care Research Utilization) Entire Class Assignme Purchase here http://chosecourses.com/hcs-465-health-care-research-utilization-entire-class-assignme Product Description HCS 465 Week 1, Individual Assignment, Annotated Bibliography Individual Assignment: Literature Review in Research: An Annotated Bibliography • Resource: Literature Review in Research: An Annotated Bibliography Grading Criteria. • Go to the Center for Writing Excellence. • Click the Tutorials & Guides link. • Click the Annotated Bibliography link the under the Samples heading. You may use this format to create your annotated bibliography. • Read: the Annotated Bibliography samples provided. • Go to any of the three main databases of the University of Phoenix Library: o EBSCOhost o Gale PowerSearch o ProQuest • Search for a health care topic to use as the basis of all individual assignments in this course. The topic must require the application of the research process described in Ch. 1 of Understanding Research. The following are examples of appropriate topics: o Teen pregnancy o Medication error o Childhood obesity o Using technology and protecting patient confidentiality and privacy o Managing the health care needs of an aging population Prepare an annotated bibliography consisting of two to three references from the University of Phoenix library to support the research on your chosen topic. Prepare a brief summary, stating whether each reference is peer reviewed. Explain how you determined if the articles were peer reviewed. Format your annotated bibliography and summary consistent with APA guidelines. HCS 465 Week 2, Applying the Background and Methodology of the Research Process to Problems in Health Care Individual Assignment: Applying the Background and Methodology of the Research Process to Problems in Health Care • Resource: Application of the Background and Methodology of the Research Process to Problems in Health Care Grading Criteria. • Choose an article from your annotated bibliography. Obtain faculty approval for your article to ensure that it is a peer-reviewed research article. • Read the following: o Background: The background statement answers the following questions: How do you know a real problem, situation, or opportunity will be studied? Does evidence indicate you have chosen an important problem, situation, or opportunity that deserves more attention? What evidence indicates that the problem, situation, or opportunity relates to an organizational management issue or clinical concern? o Methodology: This part of a research study provides an overview of the scope of the study or how large, long, and comprehensive the study was. This is a brief overview explaining the gathering of the qualitative and quantitative data and where the data may be found. Implicit in this overview is the recognition by the researcher that both secondary data—document-based data, organizational material, library books, and journals—and primary data—empirical, qualitative, and quantitative data incorporated by a survey, experiment, and so on in a real-time fashion—was gathered to make the study comprehensive, fully researched, and as rigorous as a project must be within the scientific method of data planning, gathering, and analysis. • Respond to the following questions in a 700- to 1,050-word paper: o Definition of the problem • What is the problem the study was conducted to resolve? • Why is the problem important for health care administrators to study? o Study purpose: What is the purpose of the study? o Research question • What is the main research question? • If it is not stated, what would you say the research question is? o Hypothesis or hypotheses • What is the study hypothesis? • If it is not stated, what would you say the hypothesis is? • It there is more than one study hypothesis, state the hypothesis or hypotheses. o Study variables: What are the independent and dependent study variables? o Conceptual model or theoretical framework: In what way was a conceptual model or theoretical framework used to guide this study? o Review of related literature: In what ways does the literature review support the need for this study? o Study design • What study design is used? • How many subjects were studied? • Where are the subjects found? • What organization was studied? • How long did the study take? Format your paper consistent with APA guidelines. HCS 465 Week 3, Applying the Results and Conclusion of the Research Process Individual Assignment: Applying the Results and Conclusion of the Research Process to Problems in Health Care • Resource: Applying the Results and Conclusion of the Research Process to Problems in Health Care Grading Criteria. • Use the content ofthe Applying the Background and Methodology of the Research Process to Problems in Health Care assignment, which was due in Week Two, as a guide to complete the following assignment. • Respond to the following questions in 1,050- to 1,400-word paper: o Results: data collection methods • In what way are the data collection procedures appropriate for this study? • In what way were appropriate steps taken to protect the rights of subjects? • In what way is the data collection tool used to support the reliability and validity of the study? o Data analysis procedures • In what ways are the data analysis procedures appropriate for the data collected? • In what ways are the data analysis procedures appropriate for answering the research question or questions, for testing the study hypothesis or hypotheses, or both? • What are the key distinctions between qualitative and quantitative data? o Conclusion • Summarize the findings of the study. • Identify the strengths of the scientific merit of this study. What are weaknesses? • Identify the major limitations of the scientific merit of this study? What are its weaknesses? • Explain if the findings support the hypotheses. • Format your paper consistent with APA guidelines. HCS 465 Week 4, Evaluating the Research Process Individual Assignment: Evaluating the Research Process • Resource: Evaluating the Research Process Grading Criteria. • Select one of the articles collected in the Week One Annotated Bibliography assignment. • Write a 1,400- to -1,750-word paper that evaluates the research process within your chosen article. • Explain the research process and what you can assume from the study from the following perspectives: o How is the literature review used in this research? o What are ethical considerations for data collection? o What is the data telling us in terms of statistical analysis? • Are the findings statistically significant? • Do the conclusions match the results of the study? • Do the conclusions answer the research questions in the definition of the problem? • Are the conclusions appropriate? • Do you have enough information to make a decision on the effectiveness of the study? If so, is it effective? • Format your paper consistent with APA guidelines. HCS 465 Week 5, Trends and Consumerism in Health Care Presentation Learning Team Assignment: Trends and Consumerism in Health Care Presentation • Resource: Trends and Consumerism in Health Care Presentation Grading Criteria. • Select one of the articles from the readings this week on consumerism in health care and obtain faculty approval. • Create a 10- to 15-slide Microsoft® PowerPoint® presentation, including detailed speaker notes, based on the techniques of the research process from Weeks Two and Three. • Include the following elements: o Background: Summarize the article by explaining how the article applies to customer service or consumerism in health care. What effect has research had on consumers’ perspectives on health care? o Methodology: Provide an overview of the scope of the study in the chosen article by explaining data collection and where to find the data. Describe the process used to determine validity and reliability of research findings to support evidence-based practices. o Result: Differentiate between the qualitative and quantitative aspects of the data described in the article in terms of descriptive statistics, inferential statistics, or both. Do you have enough information to make a decision on the effectiveness of the study? o Conclusions: Explain some ways to integrate the future trends of health care research and consumerism. HCS 465 Week 1 to 5 DQs 1-2 are Included

103 views • 8 slides

miRNA Sequencing and Assay Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecas

Global miRNA Sequencing and Assay Market is estimated to value over USD 330 million by 2026 end and register CAGR of over 10.8% during the forecast period 2019 to 2026. Genomics is gaining recognition as a mainstream medicine owing to its capability of identifying diseases and providing genetic study-based therapies. This has increased demand for customised medicines which needs molecular-level understanding of diseases. Therefore, the global miRNA sequencing and assay market shall gain significant traction over the forecast period. Increasing research on genomics coupled with massive financial backup being provided for this sector is the major driving factors of the market. Decreasing sequencing costs is another factor responsible for the proliferation of the market. Furthermore, rising demand for target-oriented therapies increases the demand for assay and sequencing thus bolstering the market. Moreover, increasing prevalence of cancer and complexities in treatment and diagnosis of certain cancer types is anticipated to drive the global market in upcoming years. Nonetheless, rising patient awareness on precision medicine and advancements in genomics are projected to propel the market further over the forecast period. However, a lack of skilled professionals can hamper market growth significantly. Sequencing Consumables Segment is Expected to Witness Significant Market Growth The sequencing consumables segment accounted for the largest market share in 2018 and it is expected to witness similar growth trends during the forecast period. This growth can be attributed to the rising adoption of small RNA sequencing along with an increasing demand for consumables. Academic and research institutes held the largest market share in 2018 and it is expected that this segment will showcase similar market growth during the forecast period. Availability of grants for conducting research and increasing emphasis on key market players on providing miRNA sequencing serviced and products for research applications. North America is predicted to showcase significant market growth during the forecast period owing to increasing investments in sequencing development, growing research activities in RNA biology and genomics. Furthermore, high-output techniques for analysing miRNA assays and sequencing has boosted the market growth. Key market players include Thermo Fisher Scientific, Illumina, QIAGEN, Takara Bio and NEB Request a Sample Report https://www.futurewiseresearch.com/request-sample.aspx?id=3355&page=requestsample Global miRNA Sequencing and Assay Market Segmentation: By Product u2022 Sequencing Consumables u2022 Library Preparation Kits By Technology u2022 Sequencing by Synthesis u2022 Ion Semiconductor Sequencing u2022 Sequencing by Oligonucleotide Ligation and Detection u2022 Nanopore Sequencing By End User u2022 Research and Academic Institutes u2022 Contract Research Organizations By Region u2022 North America u2022 Europe u2022 Asia Pacific u2022 Middle East & Africa u2022 Rest of the World Purchase a Copy of this Premium Research Report & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=3355&page=askfordiscount Competitive Landscape: u2022 Tier 1 players- established companies in the market with a major market share u2022 Tier 2 players u2022 Emerging players which are growing rapidly u2022 New Entrants FutureWise Key Takeaways: u2022 Growth prospects u2022 SWOT analysis u2022 Key trends u2022 Key data-points affecting market growth Objectives of the Study: u2022 To provide with an exhaustive analysis on the miRNA sequencing and assay market by product, by technology, by end user and by region u2022 To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) u2022 To evaluate and forecast micro-markets and the overall market u2022 To predict the market size, in key regions (along with countries)u2014 North America, Asia Pacific, Europe, Middle East & Africa and rest of the world u2022 To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions u2022 Profiling of companies to evaluate their market shares, strategies, financials and core competencies Table of Contents 1 Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Markets Covered 1.3.2 Years Considered for the Study 1.4 Currency 1.5 Stakeholders 1.6 Limitations 2 Research Methodology 2.1 Research Approach 2.1.1 Secondary Research 2.1.1.1 Key Data From Secondary Sources 2.1.2 Primary Research 2.1.2.1 Key Data From Primary Sources 2.1.2.2 Break Down of Primaries 2.1.2.3 Key Industry Insights 2.2 Market Size Estimation 2.3 Data Triangulation Approach 2.4 Assumptions for the Study 3 Executive Summary 4 Exclusive Insights 4.1 miRNA Sequencing & Assays Market Overview 4.2 miRNA Sequencing & Assays Market, By Technology (2014u20132026) 4.3 North America: miRNA Sequencing & Assays Market, By Product 5 Market Overview 5.1 Introduction 5.2 Market Dynamics 5.2.1 Market Drivers 5.2.1.1 Advantages of miRNA Sequencing Over Other Technologies 5.2.1.2 Increasing Research Funding for Genomics 5.2.1.3 Decreasing Cost of Sequencing 5.2.2 Market Opportunities 5.2.2.1 Increasing Focus on miRNA Biomarker Discovery 5.2.3 Market Challenges 5.2.3.1 Dearth of Skilled Professionals 6 miRNA Sequencing and Assays Market, By Product 6.2 Sequencing Consumables 6.2.1 Increasing Demand for miRNA Sequencing is Boosting the Adoption of Sequencing Consumables 6.3 Library Preparation Kits 6.3.1 Library Preparation Kits Segment to Grow at the Highest Cagr During the Forecast Period 7 miRNA Sequencing and Assays Market, By Technology 7.1 Introduction 7.2 Sequencing By Synthesis 7.2.1 Sequencing By Synthesis Segment Accounted for the Largest Market Share in 2018 7.3 Ion Semiconductor Sequencing 7.3.1 Platforms Developed Using This Technology are Low-Cost Instruments and Possess High-Throughput Capabilities 7.4 Sequencing By Oligonucleotide Ligation and Detection 7.4.1 Solid Sequencing Offers Accurate Sequencing of Short Reads 7.5 Nanopore Sequencing 7.5.1 Nanopore Sequencing Segment to Witness the Highest Growth During the Forecast Period 8 miRNA Sequencing and Assays Market, By End User 8.1 Introduction 8.2 Research and Academic Institutes 8.2.1 Research and Academic Institutes Segment to Dominate This Segment 8.3 Contract Research Organizations 8.3.1 Contract Research Organizations Such as Genomics Services Companies to Grow at Highest CAGR 9 miRNA Sequencing and Assays Market, By Region 9.1 Introduction 9.2 North America 9.2.1 US 9.2.1.1 US Dominates the North American miRNA Sequencing and Assays Market, Due to the Favorable Funding Scenario for Research and StroPlayers 9.2.2 Canada 9.2.2.1 Increase in Genomics Research to Drive the Adoption of miRNA Sequencing in Canada 9.3 Europe 9.3.1 Germany 9.3.1.1 Growth of the Genomics Market to Drive the Growth of the Market Growth 9.3.2 UK 9.3.2.1 Government Initiatives in Genomics to Drive the Market for miRNA Sequencing 9.3.3 ROE 9.4 Asia Pacific 9.5 Rest of the World 10 Competitive Landscape 10.1 Overview 10.2 Vendor Benchmarking 10.3 Competitive Leadership Mapping 10.3.1 Visionary Leaders 10.3.2 Innovators 10.3.3 Dynamic Differentiators 10.3.4 Emerging Companies 10.4 Market Ranking Analysis, 2017 10.5 Competitive Situation and Trends 10.5.1 Collaborations, Partnerships, and Agreements 10.5.2 Product Launches 10.5.3 Acquisitions 11 Company Profiles (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, FutureWise Perspective)* 11.1 Illumina, Inc. 11.2 Thermo Fisher Scientific 11.3 Qiagen 11.4 Perkinelmer, Inc. 11.5 Takara Bio, Inc. 11.6 New England Biolabs, Inc. 11.7 Norgen Biotek Corporation 11.8 Trilink Biotechnologies 11.9 Lexogen 11.10 Oxford Nanopore Technologies 12. Assumptions and Acronyms 13. Research Methodology 14. List of Sources of Information (Primary and Secondary) Inquire further details about this report at: sales@futurewiseresearch.com About FutureWise Research: We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry u2013 a position secured for far more than the near future. Contact Us: Company Name: FutureWise Research Contact Person: Vinay Thaploo Email: sales@futurewiseresearch.com Phone: 44 141 628 9353 / 1 970 279 4295 City: Leeds Country: United Kingdom Website: www.futurewiseresearch.com

110 views • 9 slides

Preclinical CRO Market Size By Top Leaders

Global Preclinical CRO Market: Information by Service (Toxicology Testing, Bioanalysis and Drug Metabolism and Pharmacokinetics (DMPK) Studies, Others), Application (Oncology, Central Nervous System (CNS) Disorders, Cardiovascular Diseases, Immunological Disorders, Respiratory Diseases, Infectious Diseases, Diabetes and Others), by End User and Region - Forecast till 2024 Read More @https://www.marketresearchfuture.com/reports/preclinical-cro-market-7274

47 views • 3 slides

Preclinical Imaging Systems | SPECT CT Scan | Preclinical MR

Find highest performing Preclinical Imaging Systems for small animals. We here at Mediso USA offer Widest Range of Preclinical Imaging Modalities. PET/CT, SPECT/CT, PET/MRI, nanoScan MRI 7T and much more. Mediso has a long history in the design, and manufacturing of high-end clinical and life science multi-modality in vivo molecular imaging systems. Contact us now at medisousa.com or call on 1.571.970.0738!

108 views • 7 slides

New FMI Report Explores Impact of COVID-19 Outbreak on Insoluble Dietary Fibre Market

Future Market Insights has revealed various facts on the global insoluble dietary fibre market in its recently published research report titled u201cInsoluble Dietary Fibre Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)u201d. This research report is filled with incisive insights and vital acumen on various factors that have contributed to the growth of the global market for insoluble dietary fibres. Along with the past market scenario, a glimpse of the future of the insoluble dietary fibre market is also portrayed, which reflects value and volume projections. The forecast analysis is for five years, from 2017 to 2027. This can assist the reader in slating important strategies based on present market conditions to achieve expansion in the coming future. A 360o view of the entire market Research study on insoluble dietary fibre market puts forth a global 3600 perspective. Main geographies across the entire globe are assessed and the trends, developments, opportunities, drivers and challenges in each region and sub region that have an influence over the growth of the market in the respective region are studied to get a clear picture of the global insoluble dietary fibre market. Revenue pockets can be identified with such kind of intense market intelligence which is unbiased in nature and purely market centric thus portraying a global perspective in front of the reader. Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-624 Unparalleled research methodology for a rock solid research study Future Market Insights follows a one of a kind research methodology to glean vital and relevant market insights. This research process ensures delivery of statistical data without errors, thus maximizing the accuracy of the research report. Secondary research in combination with primary research gives a clear market understanding based on which key players, market observers and opinion leaders are interviewed to check the reliability of the data and to add other facets of the market. The uniqueness of this research process is the revalidation and re-evaluation of the data that takes place at each step during each interview and is continued till the conclusion of the market research. Based on these vital acumen, key analysis can be drawn and recommendations from domain experts are included in this intelligence report. The multiple cross checking of the data ensures a highly accurate market scenario which can be directly used by the reader to chalk informed decisions. Market Segmentation The global research report on insoluble dietary fibre market includes an in-depth analysis on each segment of the entire market. The market segmentation covers product type, source, application and region. By Product Type Cellulose Hemicellulose Chitin and Chitosan Lignin Bran Resistant Starch Others By Source Fruits Exotic Fruits Citrus Fruits Others By Application Vegetables Cereals and Grains Legumes Others Pet Food Functional Food and Beverages Pharmaceuticals and Dietary Supplements Others By Region North America Latin America Western Europe Eastern Europe Asia Pacific excluding Japan (APEJ) Japan Middle East and Africa (MEA) The research report on global insoluble dietary fibre market covers analysis on key companies participating in this market. Various aspects such as SWOT analysis, key developments, innovations, product portfolio, financials and company overview are included in this section of the report. The reader can gain intelligence on the major players that have a good hold in the market, based on which new strategies can be devised to gain an edge on the competition. To Buy This Research Report @ https://www.futuremarketinsights.com/checkout/624 The weighted market analysis on global insoluble dietary fibre market delivers value to the reader by providing drinkable insights, ready to use statistical analysis and recommendations without biasness in order to plan future expansion strategies and also to gain stability in the changing dynamics of the global market. ABOUT US: Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India. FMIu2019s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers. CONTACT US: Mr. Abhishek Budholiya Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A, Jumeirah Lakes Towers, Dubai, United Arab Emirates MARKET ACCESS DMCC Initiative For Sales Enquiries: sales@futuremarketinsights.com For Media Enquiries: press@futuremarketinsights.com

105 views • 9 slides

Continuous Manufacturing Market (Small Molecules and Biologics), 2020 – 2030, By Roots

To order this 310 page report, which features 110 figures and 200 tables, please visit this - https://www.rootsanalysis.com/reports/view_document/continuous-manufacturing/308.html Key Inclusions uf0a7tA detailed assessment of the overall landscape of companies with capabilities for continuous manufacturing, along with information on a number of relevant parameters, such as year of establishment, company size, purpose of manufacturing (in-house and contract services), scale of operation (preclinical, clinical and commercial), location of headquarters, location of manufacturing facilities, type of drug molecule (biologic and small molecule), type of continuous manufacturing related service(s) offered (process development, API manufacturing, intermediate manufacturing, drug product manufacturing, and packaging and fill / finish), type of dosage form (solid and liquid), and installed capacity and batch size (if available). uf0a7tElaborate profiles of some of the key contract manufacturers active in the pharmaceutical and biopharmaceutical continuous manufacturing market in North America, Europe and Asia-Pacific. Each profile features an overview of the company, along with information related to its service portfolio, continuous manufacturing capabilities and facilities, recent developments and an informed future outlook. uf0a7tAn analysis of the various partnerships related to continuous manufacturing, which have been established since 2013, based on several parameters, such as year of an agreement, the type of partnership (research agreements, facility development / establishment agreements, technology enhancement agreements, service alliances, process development agreements, manufacturing agreements and other relevant agreements), scale of operation (preclinical, clinical and commercial), type of drug molecule (biologic and small molecule), type of continuous manufacturing related service (API manufacturing, intermediate manufacturing and end product manufacturing) and type of dosage form (solid and liquid). It also provides the regional distribution of the collaborations. uf0a7tAn analysis of the expansions related to continuous manufacturing, which have been established since 2013, based on several parameters, such as year of an expansion and the type of expansion (facility / plant expansion, technology installation, technology enhancement and service expansion), geographical location of the facility, scale of operation (preclinical, clinical and commercial), type of drug molecule (biologic and small molecule), type of continuous manufacturing related service (API manufacturing, intermediate manufacturing and end product manufacturing) and type of dosage form (solid and liquid). uf0a7tAn estimate of the global, continuous manufacturing capacity, based on the capacities of various industry stakeholders (as available on their respective company websites). The study examines the distribution of capacity, based on the type of drug molecule (biologic and small molecule), company size (small-sized, mid-sized and large), scale of operation (preclinical, clinical and commercial), location of headquarters (North America, Europe and Asia-Pacific) and location of manufacturing facilities (North America, Europe and Asia-Pacific). uf0a7tA study of the various grants that have been awarded to research institutes engaged in projects related to continuous manufacturing, between 2014 and 2019, highlighting multiple parameters, such as year of award, type of grant, grant amount, focus area, support period, popular recipient organizations, type of recipient organization, funding institute center, funding mechanism and prominent program officers. uf0a7tAn in-depth analysis of the various patents that have been filed / granted related to continuous manufacturing till 2019. It includes information on key parameters, such as patent type, publication year, geographical location, CPC symbol, emerging focus areas, type of applicant and leading industry / non-industry players (in terms of the size of intellectual property portfolio). It also features a three-dimensional bubble analysis (based on patent citation count, publication year, extended geographical reach), as well as a patent benchmarking and a detailed valuation analysis. uf0a7tInitiatives taken by the leading pharmaceutical companies (in terms of revenues), covering both partnered as well as in-house projects. uf0a7tA review of the companies offering modular facilities / modular cleanrooms, with information on their geographical location (North America, Europe, Asia-Pacific and rest of the world), year of establishment, company size (small-sized, mid-sized or large) and type of industries served (pharmaceutical, biotechnology or others). It also includes information on the recent projects undertaken / executed by the companies providing modular facilities. uf0a7tA case study of the companies offering technologies / equipment (continuous blenders and mixers, continuous granulators, continuous dryers, continuous compressors, continuous coaters, flow reactors, continuous filtration, distillation and centrifugation equipment, continuous chromatography, PAT technology and other technologies) that can potentially be used in a continuous manufacturing process, providing information on the geographical location of potential stakeholders and the type of technology / equipment provided. uf0a7tA case study on the roadmap for the adoption of continuous manufacturing technique, discussing different strategies that can be followed by the company in order to adopt this technology or transition from batch manufacturing to continuous manufacturing. The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below: uf0a7tPurpose of Manufacturing uf0a7tIn-House uf0a7tContract service uf0a7tScale of Operation uf0a7tCommercial uf0a7tPreclinical / Clinical uf0a7tType of Continuous Manufacturing related Service uf0a7tAPI Manufacturing uf0a7tEnd Product manufacturing uf0a7tType of Drug Molecule uf0a7tBiologic uf0a7tSmall Molecule uf0a7tType of dosage form uf0a7tSolid uf0a7tLiquid uf0a7tKey Geographical Regions uf0a7tNorth America uf0a7tEurope uf0a7tAsia Pacific uf0a7tTranscripts of interviews held with the following senior level representatives of stakeholder companies uf0a7tAndrea Adamo, Founder and Chief Executive Officer, Zaiput Flow technologies uf0a7tBayan Takizawa, Co-Founder and Chief Business Officer, CONTINUUS Pharmaceuticals uf0a7tNick Thomson, Senior Director Chemical Research and Development, Pfizer uf0a7tHimanshu Gadgil, Director and Chief Scientific Officer, Enzene Biosciences uf0a7tEric Fang, Chief Scientific Officer, Snapdragon Chemistry) uf0a7tIan Houson, Technical Project Manager, Continuous Manufacturing and Crystallization, University of Strathclyde To request sample pages, please visit this - https://www.rootsanalysis.com/reports/312/request-sample.html Key Questions Answered uf0a7tWho are the key players engaged in continuous manufacturing of small molecules and biologics? uf0a7tWhat is the installed, global capacity for continuous manufacturing? uf0a7tWhat are the key growth drivers within this domain? uf0a7tWhat are the various paths to evolution within this industry? uf0a7tWho are the other key stakeholders (modular facility providers and technology / equipment developers) in this domain? uf0a7tHow is the current and future market opportunity likely to be distributed across key market segments? You may also be interested in the following titles: 1.tPharmaceutical Contract Manufacturing Market (2nd Edition), 2018-2028 2.tBiopharma Contract Manufacturing Market (3rd Edition), 2019 - 2030 3.tChina Pharmaceutical Contract Manufacturing Services Market, 2020-2030 4.tChina Biopharmaceutical Contract Manufacturing Market, 2020 - 2030 Contact Us Gaurav Chaudhary 1 (415) 800 3415 gaurav.chaudhary@rootsanalysis.com

27 views • 1 slides

Preclinical Imaging Market Report 2027

The global preclinical imaging anticipated to have held a market value of USD 2.01 billion in the year 2017 and is expected to grow at a CAGR of 6.3% during the forecast period. Preclinical imaging solutions are used during the preclinical research for visualization of living animals. It is playing important role during drug development process. It is evaluating the effectiveness and safety of new treatments and describing drug distribution patterns before clinical use. preclinical imaging solutions has broad application field such as, neurology; cardiology; inflammation; infectious diseases; cancer research; functional and anatomical neuroimaging, orthopedics; and cardiac imaging.

54 views • 5 slides

What to look at while Choosing a CRO Company for Clinical Trials

Do you need dermatology CRO for your preclinical research? Vial Trials is here to help you! With our strong expertise in vitro and ex vivo models and skin physiology, we aim to help you meet your preclinical research objectives. We assist you with your development projects as well as with the validation of your products. To know more, visit our website!

108 views • 9 slides

Preclinical Respiration and Inhalation Lab Equipment Market Set to Witness Huge Growth by 2028

Preclinical Respiration And Inhalation Lab Equipment Market is expected to witness market growth at a rate of 2.95% in the forecast period of 2021 to 2028 and is expected to reach USD 2.46 million by 2028. Data Bridge Market Research report on preclinical respiration and inhalation lab equipment market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the marketu2019s growth. . The recent COVID-19 pandemic is escalating the growth of preclinical respiration and inhalation lab equipment market.

41 views • 3 slides

Preclinical In-vivo Imaging Market Report 2022-2029

North America region has highest market share in the global Preclinical In-vivo Imaging Market report, and it is further continue its dominance during the forecast period 2022-2029. Asia Pacific region is largest market share in global Market. Preclinical In-vivo Imaging Market in Europe region is expected to record a decent growth over the forecast period.

29 views • 2 slides

Preclinical In-vivo Imaging Market Competitive Landscape 2023-2030

Emerging factors leading to the global preclinical in-vivo imaging market growth contain the advancements in new technological molecular imaging, rising interest in non-invasive small animal imaging methods, and a surge in preclinical research funding from both public and private organizations

106 views • 10 slides

Preclinical Imaging Market Size Trends Insights 2023

Preclinical Imaging Market Outlook, 2023- Forecasts and Opportunities in the Preclinical Imaging Industry by Type (Devices, Reagents, Services), Technologies (Optical Imaging, Micro MRI, Micro PET, SPECT, Micro Ultrasound, Micro CT, Photoacoustic (PAT) Imaging, Others), Companies and Countries to 2030

48 views • 3 slides

READ [PDF] Research: Successful Approaches in Nutrition and Dietetics , Fourth Edition

18 minutes ago - COPY LINK TO DOWNLOAD : https://koencoeng-ygtersakity.blogspot.mx/?lophe=0880919469 | [PDF READ ONLINE] Research: Successful Approaches in Nutrition and Dietetics , Fourth Edition | For over 25 years, this highly respected resource has presented the evolving collective knowledge of the foremost research experts in the field of nutrition and dietetics. This fully revised fourth edition addresses designing, executing, analyzing, and communicating modern nutrition research that is essential for today s evidence-based practice. From formulating hypotheses, research questions, and study design to ethical research conduct, writing proposals, and securing funding, this reference builds a strong research foundation, making research accessible for all readers. Sections devoted to the key types of research and assessment methods used in the study of nutrition and dietetics offer in-depth coverage of new and different tools and methodologies, including - When and how to use qualitative research - Observational and experimental research, including analytic nutrition epidemiology and guidelines for conducting clinical nutrition studies - Integrative and translational research, including the value of systematic reviews and interdisciplinary research -Evaluation and assessment methods, including survey research, dietary assessment methods, food composition analysis, appetite assessment, and more -Research in expanding areas of practice nutrigenomics, behavioral health, dietary supplements, foodservice management, community settings, integrative nutrition, and dietetics education. Evaluation and application of research findings are also addressed in chapters on statistical analysis, presentation of research data, and bridging research results into practice.

21 views • 4 slides

More Related